Giant mitochondria in hepatocytes: a diagnostic hint for alcoholic liver disease

Gastroenterology
|December 1, 1977
PubMed

Insights

Giant mitochondria, identified in liver biopsies, are significantly more common in heavy drinkers. Their presence suggests recent and heavy alcohol consumption, serving as a diagnostic hint.

Area of Science:

  • Hepatology
  • Cellular Pathology

Background:

  • Giant mitochondria are periodic acid-Schiff-negative cytoplasmic inclusions.
  • Distinguishing them from Mallory bodies is crucial in liver pathology.

Purpose of the Study:

  • To evaluate the occurrence and diagnostic significance of giant mitochondria in liver biopsies.
  • To correlate giant mitochondria presence with alcohol consumption levels.

Main Methods:

  • Light microscopy of 165 coded liver biopsy specimens.
  • Electron microscopy confirmation in 4 cases.
  • Analysis of giant mitochondria incidence relative to alcohol intake and abstinence duration.

Main Results:

  • Giant mitochondria were found in 72% of patients with high alcohol consumption versus 10% with low/no intake.
  • Presence correlated with daily ethanol intake and shorter abstinence periods.
  • Detected across various alcoholic liver diseases, independent of other liver changes.

Conclusions:

  • Giant mitochondria are detectable by light microscopy in a majority of alcoholics.
  • They serve as a valuable diagnostic hint for recent and heavy alcohol abuse.
  • More frequent than Mallory bodies, though less specific.

Related Concept Videos

Liver Histology01:27

Liver Histology

The microscopic anatomy of the liver is a complex and intricate system that comprises numerous structural units known as liver lobules, each of which is comparable in size to a sesame seed. These hexagonal structures consist of plates of liver cells or hepatocytes, which are characterized by their versatility and abundance of cellular apparatus like rough and smooth ER, Golgi apparatus, peroxisomes, and mitochondria.
Hepatocytes perform a variety of essential functions. They secrete...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...